Katherine To

Katherine To has over 15 years of experience in clinical operations, study management, and clinical trials. Katherine began their career in 2004 as a Clinical Trial Associate at On Assignment. In 2005, they joined Amgen as a Clinical Trial Specialist and progressed to Clinical Research Study Manager, Sr. Manager Global Study Management, and Director Global Study Management. In 2021, they joined Acyerlin, Inc. as Vice President Clinical Operations and Sr. Director Clinical Operations. During their time at Amgen, they were the Clinical Study Management Lead for the Amgen Biosimilars Inflammation Portfolio, overseeing multiple molecules at various stages of development. Katherine has experience in biosimilars, inflammation, oncology, and ophthalmology therapeutic areas.

Katherine To obtained a Master of Science in Regulatory Science from the University of Southern California in 2008 and a Bachelor of Science in Biomedical (Biochemical) Engineering from the same university in 2004.